| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Karolina Kozak Bidzinski, Darby J E Lowe, Marcos Sanches, Maryam Sorkhou, Isabelle Boileau, Michael Kiang, Daniel M Blumberger, Gary Remington, Clement Ma, David J Castle, Rachel A Rabin, Tony P Georg. Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia. NPJ schizophrenia. vol 8. issue 1. 2022-02-25. PMID:35210458. |
we examined the effects of active versus sham high-frequency (20-hz) repetitive transcranial magnetic stimulation (rtms) on cannabis use in outpatients with schizophrenia and cud. |
2022-02-25 |
2023-08-13 |
human |
| Bryan W Jenkins, Shoshana Buckhalter, Melissa L Perreault, Jibran Y Khokha. Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents. Schizophrenia bulletin open. vol 3. issue 1. 2022-01-17. PMID:35036917. |
cannabis vapor exposure alters neural circuit oscillatory activity in a neurodevelopmental model of schizophrenia: exploring the differential impact of cannabis constituents. |
2022-01-17 |
2023-08-13 |
rat |
| Bryan W Jenkins, Shoshana Buckhalter, Melissa L Perreault, Jibran Y Khokha. Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents. Schizophrenia bulletin open. vol 3. issue 1. 2022-01-17. PMID:35036917. |
cannabis use is highly prevalent in patients with schizophrenia and worsens the course of the disorder. |
2022-01-17 |
2023-08-13 |
rat |
| Bryan W Jenkins, Shoshana Buckhalter, Melissa L Perreault, Jibran Y Khokha. Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents. Schizophrenia bulletin open. vol 3. issue 1. 2022-01-17. PMID:35036917. |
to understand how exposure to cannabis changes schizophrenia-related oscillatory disruptions, we investigated the impact of administering cannabis vapor containing either Δ9-tetrahydrocannabinol (thc) or balanced thc/cannabidiol (cbd) on oscillatory activity in the neonatal ventral hippocampal lesion (nvhl) rat model of schizophrenia. |
2022-01-17 |
2023-08-13 |
rat |
| Christopher Dawes, Declan Quinn, Andrea Bickerdike, Cian O'Neill, Kiri T Granger, Sarah Carneiro Pereira, Sue Lynn Mah, Mark Haselgrove, John L Waddington, Colm O'Tuathaigh, Paula M Mora. Latent inhibition, aberrant salience, and schizotypy traits in cannabis users. Schizophrenia research. Cognition. vol 28. 2022-01-14. PMID:35028297. |
aberrant salience processing may underlie the link between cannabis and psychosis, as posited in individuals with schizophrenia or high schizotypy. |
2022-01-14 |
2023-08-13 |
human |
| Shea-Lee Godin, Sherif Shehat. Adolescent cannabis use and later development of schizophrenia: An updated systematic review of longitudinal studies. Journal of clinical psychology. 2022-01-12. PMID:35018649. |
adolescent cannabis use and later development of schizophrenia: an updated systematic review of longitudinal studies. |
2022-01-12 |
2023-08-13 |
Not clear |
| Shea-Lee Godin, Sherif Shehat. Adolescent cannabis use and later development of schizophrenia: An updated systematic review of longitudinal studies. Journal of clinical psychology. 2022-01-12. PMID:35018649. |
a further aim was to determine if the frequency of use of marijuana demonstrated any significant effect on the risk of developing schizophrenia in early adulthood. |
2022-01-12 |
2023-08-13 |
Not clear |
| Russell C Callaghan, Marcos Sanches, Robin M Murray, Sarah Konefal, Bridget Maloney-Hall, Stephen J Kis. Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019. Canadian journal of psychiatry. Revue canadienne de psychiatrie. 2022-01-12. PMID:35019734. |
associations between canada's cannabis legalization and emergency department presentations for transient cannabis-induced psychosis and schizophrenia conditions: ontario and alberta, 2015-2019. |
2022-01-12 |
2023-08-13 |
Not clear |
| Bruno Romeo, Valentine Lestra, Catherine Martelli, Amine Benyamina, Nora Hamdan. Cannabis Cessation, Inflammatory Markers and Schizophrenia. Journal of dual diagnosis. 2022-01-05. PMID:34985404. |
cannabis cessation, inflammatory markers and schizophrenia. |
2022-01-05 |
2023-08-13 |
Not clear |
| Todd M Stollenwerk, Cecilia J Hillar. Adolescent THC Treatment Does Not Potentiate the Behavioral Effects in Adulthood of Maternal Immune Activation. Cells. vol 10. issue 12. 2021-12-24. PMID:34944011. |
both in utero exposure to maternal immune activation and cannabis use during adolescence have been associated with increased risk for the development of schizophrenia; however, whether these exposures exert synergistic effects on brain function is not known. |
2021-12-24 |
2023-08-13 |
mouse |
| Rachit Sharma, Ayushma Sha. Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma. Industrial psychiatry journal. vol 30. issue Suppl 1. 2021-12-15. PMID:34908722. |
we present a case of cannabis dependence syndrome, whose first presentation was with first-rank symptoms of schizophrenia in the form of thought insertion, withdrawal and delusion of control. |
2021-12-15 |
2023-08-13 |
Not clear |
| Jim van Os, Lotta-Katrin Pries, Margreet Ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak, Hans-Ulrich Wittchen, Bart P F Rutten, Sinan Guloksu. Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association-The Example of Cannabis and Psychosis. Schizophrenia bulletin. vol 47. issue 3. 2021-11-22. PMID:33693921. |
schizophrenia and the environment: within-person analyses may be required to yield evidence of unconfounded and causal association-the example of cannabis and psychosis. |
2021-11-22 |
2023-08-13 |
Not clear |
| Marta Kruk-Slomka, Grazyna Bial. Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice. Molecules (Basel, Switzerland). vol 26. issue 19. 2021-11-18. PMID:34641522. |
cannabidiol attenuates mk-801-induced cognitive symptoms of schizophrenia in the passive avoidance test in mice. |
2021-11-18 |
2023-08-13 |
mouse |
| Carsten Hjorthøj, Maria Oku Larsen, Marie Stefanie Kejser Starzer, Merete Nordentof. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016. Psychological medicine. vol 51. issue 4. 2021-11-15. PMID:31839011. |
annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in denmark from 1994 to 2016. |
2021-11-15 |
2023-08-13 |
Not clear |
| Carsten Hjorthøj, Maria Oku Larsen, Marie Stefanie Kejser Starzer, Merete Nordentof. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016. Psychological medicine. vol 51. issue 4. 2021-11-15. PMID:31839011. |
we aimed to investigate (1) the development of incidence of cannabis-induced psychosis over time compared with other substance-induced psychoses and (2) the development of incident cases of cannabis-induced psychosis over time compared with dual diagnosis defined as schizophrenia and a cannabis use disorder. |
2021-11-15 |
2023-08-13 |
Not clear |
| Carsten Hjorthøj, Md Jamal Uddin, Theresa Wimberley, Søren Dalsgaard, David M Hougaard, Anders Børglum, Thomas Werge, Merete Nordentof. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:31813396. |
no evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. |
2021-11-12 |
2023-08-13 |
Not clear |
| Carsten Hjorthøj, Md Jamal Uddin, Theresa Wimberley, Søren Dalsgaard, David M Hougaard, Anders Børglum, Thomas Werge, Merete Nordentof. No evidence of associations between genetic liability for schizophrenia and development of cannabis use disorder. Psychological medicine. vol 51. issue 3. 2021-11-12. PMID:31813396. |
cannabis use and cannabis use disorder (cud) is increased in patients with schizophrenia. |
2021-11-12 |
2023-08-13 |
Not clear |
| João F C Pedrazzi, Amanda J Sales, Francisco S Guimarães, Sâmia R L Joca, José A S Crippa, Elaine Del Be. Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum. Progress in neuro-psychopharmacology & biological psychiatry. vol 111. 2021-11-11. PMID:34015384. |
cannabidiol (cbd), a major non-psychotomimetic component of the cannabis sativa plant, shows therapeutic potential in several psychiatric disorders, including schizophrenia. |
2021-11-11 |
2023-08-13 |
mouse |
| Lisa-Marie Greenwood, Samantha J Broyd, Hendrika H van Hell, Juanita Todd, Alison Jones, Robin M Murray, Rodney J Croft, Patricia T Michie, Nadia Solowi. Acute effects of Δ Psychopharmacology. 2021-11-01. PMID:34719731. |
acute effects of Δ mismatch negativity (mmn) is a candidate endophenotype for schizophrenia subserved by n-methyl-d-aspartate receptor (nmdar) function and there is increasing evidence that prolonged cannabis use adversely affects mmn generation. |
2021-11-01 |
2023-08-13 |
human |
| Alejandra Delgado-Sequera, María Hidalgo-Figueroa, Marta Barrera-Conde, Mª Carmen Duran-Ruiz, Carmen Castro, Cristina Fernández-Avilés, Rafael de la Torre, Ismael Sánchez-Gomar, Víctor Pérez, Noelia Geribaldi-Doldán, Patricia Robledo, Esther Berrocos. Olfactory Neuroepithelium Cells from Cannabis Users Display Alterations to the Cytoskeleton and to Markers of Adhesion, Proliferation and Apoptosis. Molecular neurobiology. vol 58. issue 4. 2021-10-27. PMID:33237429. |
our results indicate that cannabis may alter key processes of the developing brain, some of which are similar to those reported in mental disorders like digeorge syndrome, schizophrenia and bipolar disorder. |
2021-10-27 |
2023-08-13 |
human |